Barron's4d
Novo Nordisk A/S ADR
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
AOL12d
'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen
He added that the US market relies heavily on generic drugs rather than branded products, which Novo Nordisk does not sell. Competitor Eli Lilly (LLY) recently announced a $27 billion investment in ...
Daily Maverick14d
South African watchdog probes Novo Nordisk and Sanofi over insulin
South Africa's competition watchdog probes Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market South Africa’s competition watchdog is investigating ...
Business Wire15d
Gensaic Announces Collaboration with Novo Nordisk to Unlock Next Generation Precision Therapies
This collaboration unites Novo Nordisk’s deep therapeutic knowledge and drug development experience with Gensaic’s novel protein design technology with the aim to discover tissue targeting ...
Insider Monkey16d
Novo Nordisk A/S (NYSE:NVO): A Strong Pipeline to Aid Recovery
We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on ValueInvestorsClub by cable888. In this article, we will summarize the bulls’ thesis on NVO. The company’s shares were trading ...
Ekstra Bladet20d
Novo-direktør stopper efter 23 år
Novo Nordisk skal have ny kommunikationsdirektør. Efter 23 år hos den danske medicinalgigant har Katrine Sperling valgt at forlade sin post. Det fremgår af et opslag på LinkedIn: 'Beslutningen ...
Euroinvestor20d
Novo Nordisk scorer regnskabssæsonens bedste karakter: 'Det slutter godt'
Han har blandt andet taget et kig på medicinalgiganten Novo Nordisk, hvis regnskab han har givet karakteren 10. Det er den højeste karakter, han har uddelt i denne regnskabssæson. Udover Novo Nordisk ...
BT21d
Novo Nordisk direktør stopper efter 23 år
Novo Nordisk skal ud og finde en ny kommunikationsdirektør. For Katrine Sperling stopper efter 23 år på posten. Det skriver hun på LinkedIn. »Jeg har taget en modig beslutning og skal starte et nyt ...
pharmaphorum21d
Novo Nordisk snaps up RNAi partner Dicerna in $3.3bn takeover deal
Danish drugmaker Novo Nordisk must like what it has seen in its two-year-old alliance with gene-silencing specialist Dicerna Pharma – it has just agreed to acquire the biotech for $3.3 billion ...
Philippine Daily Inquirer21d
Novo Nordisk and PCEDM sign a partnership agreement against serious non-communicable diseases
As Heart Month reminds us of the critical need to protect our cardiovascular and metabolic (CVM) health, Novo Nordisk Philippines and the Philippine College of Endocrinology, Diabetes, and ...
MarketWatch21d
Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...